DrugDashboards

Market view

clindamycin in 5 percent dextrose

7 marketed package NDCs · 3 active manufacturers

The short version

Just 3 companies supply this market — thin enough that a single exit would be felt immediately. It is in shortage right now.

Same drug class

Other molecules FDA puts in Lincosamide Antibacterial, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Clindamycin in 5 percent dextrose in shortage right now?
Yes. FDA currently lists Clindamycin in 5 percent dextrose in shortage. This page is rebuilt every morning from FDA's shortage database.
Who makes Clindamycin in 5 percent dextrose?
3 companies have marketed Clindamycin in 5 percent dextrose in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.

Shortage reports for this molecule

  • In shortage nowClindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 0781-3289-09)Mar 21, 2023
  • In shortage nowClindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 72572-074-24)Mar 21, 2023
  • In shortage nowClindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC 0781-3290-09)Mar 21, 2023
  • In shortage nowClindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC 72572-076-24)Mar 21, 2023
  • In shortage nowClindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 6 mg/1 mL (NDC 0781-3288-09)Mar 21, 2023

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.